Skip to content

Investing Cash Flow at other companies

Procter & Gamble logo
Procter & GamblePG
-$665M+8.4%
Johnson & Johnson logo
Johnson & JohnsonJNJ
-$1.04B-250%
Perrigo Company logo
Perrigo CompanyPRGO
-$12.4M+51.8%
HRO
HarrowHROW
-$18.2M-8,486%
Opko Health logo
Opko HealthOPK
-$1.8M-104%
Bausch Health Companies logo
Bausch Health CompaniesBHC
-$139M-6.9%

Other financials

Income statement

See full
Revenue$281.6M-5.0%
Gross profit$146.3M-13.9%
Operating income$75.5M-14.6%
Net income$53.9M+7.6%
EPS (diluted)$1.13+11.9%

Balance sheet

See full
Cash & equivalents$63.9M-34.8%
Total debt$1.0B-0.2%
Total equity$1.9B+2.9%
Total assets$3.5B+2.7%

Cash flow

See full
Operating cash flow$42.8M-30.7%
CapEx$5.2M+49.8%
Free cash flow$37.6M-35.5%

Valuation

See full
Market cap$2.24B-34.1%
Enterprise value$3.22B-27.3%
P/E11.8×-4.1×
P/S2.1×-0.9×

Profitability

See full
Gross margin54.7%-1.1pp
Operating margin28.4%-1.2pp
Net margin17.5%-1.4pp
FCF margin22.6%+1.3pp

Returns & leverage

See full
Return on equity10.2%-2.1pp
Debt / equity0.6×0.0×
Current ratio3.6×-0.6×

Where this comes from

Reported directly by Prestige Consumer Healthcare in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Prestige Consumer Healthcare’s 10-K, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prestige Consumer Healthcare's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Prestige Consumer Healthcare's investing cash flow?
Prestige Consumer Healthcare (PBH) reported investing cash flow of -$3.41M in Q1 2026.
How has Prestige Consumer Healthcare's investing cash flow changed year-over-year?
Prestige Consumer Healthcare's investing cash flow increased by 1.9% year-over-year, from -$3.48M to -$3.41M.
What is the long-term trend for Prestige Consumer Healthcare's investing cash flow?
Over 4 years (2022 to 2026), Prestige Consumer Healthcare's investing cash flow has grown at a -14.5% compound annual growth rate (CAGR), from -$256.51M to -$136.84M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.